Skip to main content
. 2019 Sep 13;18(5):5043–5054. doi: 10.3892/ol.2019.10866

Figure 7.

Figure 7.

Gene set enrichment analysis of CEACAM7. Two significantly enriched pathways were identified in the low CEACAM7 expression group of patients with CRC at nominal P<0.05 and FDR<0.25, including (A) glycosaminoglycan biosynthesis-chondroitin sulfate (nominal P=0.002; FDR, 0.101) and (B) ECM receptor interaction (nominal P=0.022; FDR, 0.151). CEACAM7, carcinoembryonic antigen-related cell adhesion molecule 7; CRC, colorectal cancer; NES, normalized enrichment score; FDR, false discovery rate; ECM, extracellular matrix.